Wandisco (WANSF) Stock Rating Lowered by Zacks Investment Research

Wandisco (OTCMKTS:WANSF) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Saturday. They currently have a $13.00 price target on the stock. Zacks Investment Research‘s price target suggests a potential upside of 12.07% from the stock’s current price.

According to Zacks, “WANdisco plc involved in the development and provision of collaboration software. The Company offers active data replication which enables data editing to the cloud and on-premises data centers as well as provides data migration, disaster recovery and hybrid cloud solutions. It also offers cloud services, such as Amazon S3 active migrator, Google cloud active migrator, and Fusion hybrid cloud services as well as provides software maintenance services. WANdisco plc is based in Sheffield, the United Kingdom. “

How to Become a New Pot Stock Millionaire

Shares of OTCMKTS WANSF remained flat at $$11.60 during mid-day trading on Friday. Wandisco has a 1-year low of $5.30 and a 1-year high of $12.25.

TRADEMARK VIOLATION WARNING: “Wandisco (WANSF) Stock Rating Lowered by Zacks Investment Research” was first published by Ticker Report and is owned by of Ticker Report. If you are reading this story on another website, it was illegally stolen and reposted in violation of US and international copyright legislation. The correct version of this story can be accessed at https://www.tickerreport.com/banking-finance/3338824/wandisco-wansf-stock-rating-lowered-by-zacks-investment-research.html.

Wandisco Company Profile

WANdisco plc engages in the development and provision of collaboration software worldwide. It offers WANdisco Fusion, a general-purpose replication platform transfers data across various environments with guaranteed consistency, no downtime, and no data loss. In addition, the company offers cloud migration, cloud replication, data lakes, developer collaboration, disaster recovery, hybrid cloud, Internet of things, and real-time analytics solutions.

Get a free copy of the Zacks research report on Wandisco (WANSF)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Wandisco Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wandisco and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Perrigo  Given a $105.00 Price Target by Canaccord Genuity Analysts
Perrigo Given a $105.00 Price Target by Canaccord Genuity Analysts
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Proteostasis Therapeutics  Stock Price
Somewhat Favorable Media Coverage Somewhat Unlikely to Affect Proteostasis Therapeutics Stock Price
FTD Companies  Getting Somewhat Positive Press Coverage, Report Shows
FTD Companies Getting Somewhat Positive Press Coverage, Report Shows
Koovs  Stock Price Up 28.2%
Koovs Stock Price Up 28.2%
Rigel Pharmaceuticals   Shares Down 6.5%
Rigel Pharmaceuticals Shares Down 6.5%
Dicerna Pharmaceuticals  Shares Up -6.6%
Dicerna Pharmaceuticals Shares Up -6.6%


© 2006-2018 Ticker Report. Google+.